世界の内視鏡的粘膜下層剥離術(ESD)市場:製品別(把持器、クリップ、胃カメラ、大腸カメラ)、疾患別、エンドユーザー別

◆英語タイトル:Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027

MarketsandMarketsが発行した調査報告書(MD8238-23)◆商品コード:MD8238-23
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2023年1月11日
◆ページ数:197
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥732,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥984,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,206,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

MarketsandMarkets社では、世界の内視鏡的粘膜下層剥離術(ESD)市場規模が、2022年347百万ドルから2027年483百万ドルまで年平均6.9%成長すると予測しています。当調査資料は、内視鏡的粘膜下層剥離術(ESD)の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(胃カメラ&大腸カメラ、ナイフ、注射剤、組織収納具、その他)分析、疾患別(胃癌、結腸癌、食道癌)分析、エンドユーザー別(病院、専門クリニック、外来手術センター、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況など、以下の構成でまとめております。なお、当書には、Olympus Corporation (Japan)、Boston Scientific Corporation (US)、Sumitomo Bakelite Co.,Ltd. (Japan)、Creo Medical Group PLC (UK)、Medtronic (Ireland)、HOYA Corporation (Japan)、ConMed Corporation (US)、Steris Plc (Ireland)、FUJIFILM Holdings Corporation (Japan)、MTW Endoskopie Manufaktur (Germany)、Ovesco Endoscopy AG (Germany)などの主要企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要

・世界の内視鏡的粘膜下層剥離術(ESD)市場規模:製品別
- 胃カメラ&大腸カメラの市場規模
- ナイフの市場規模
- 注射剤の市場規模
- 組織収納具の市場規模
- その他製品の市場規模

・世界の内視鏡的粘膜下層剥離術(ESD)市場規模:疾患別
- 胃癌の市場規模
- 結腸癌の市場規模
- 食道癌の市場規模

・世界の内視鏡的粘膜下層剥離術(ESD)市場規模:エンドユーザー別
- 病院における市場規模
- 専門クリニックにおける市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模

・世界の内視鏡的粘膜下層剥離術(ESD)市場規模:地域別
- 北米の内視鏡的粘膜下層剥離術(ESD)市場規模
- ヨーロッパの内視鏡的粘膜下層剥離術(ESD)市場規模
- アジア太平洋の内視鏡的粘膜下層剥離術(ESD)市場規模
- 中南米の内視鏡的粘膜下層剥離術(ESD)市場規模
- 中東/アフリカの内視鏡的粘膜下層剥離術(ESD)市場規模

・競争状況
・企業情報
❖ レポートの概要 ❖

“世界の内視鏡的粘膜下層剥離術(ESD)市場は2022年の3億4700万米ドルから2027年には4億8300万米ドルに達し、年平均成長率は6.9%と予測”
内視鏡的粘膜下層剥離術(ESD)は、表在性消化管新生物に対する高度な治療内視鏡技術です。内視鏡的粘膜下層剥離術(ESD)では、さまざまな種類のナイフ、鉗子、スネア、その他手技をサポートするいくつかの製品、手術中の器具の取り扱いを容易にするために使用される付属品が機器に含まれます。

世界の内視鏡的粘膜下層剥離術(ESD)市場は、2022年の3億4,700万米ドルから2027年には4億8,300万米ドルに達し、年平均成長率は6.9%になると予測されています。この市場の成長は、検出および治療手順における内視鏡の使用の増加、癌の有病率の上昇、高齢者人口の増加が主な要因です。一方、熟練した専門家が少ないことが、この市場の成長を抑制する主な要因となっています。

“内視鏡的粘膜下層剥離術(ESD)の世界市場では胃カメラ・大腸カメラ分野が最大シェアを占める”
2021年、内視鏡的粘膜下層剥離術(ESD)の世界市場では、胃カメラ・大腸カメラセグメントが最大のシェアを占めています。このセグメントの大きなシェアは、エンドユーザーによるこの機器の高い採用率、低侵襲処置に対する患者や医師の嗜好の高まり、内視鏡処置における継続的な技術進歩に起因しています。

“胃がんセグメントが2021年の内視鏡的粘膜下層剥離術(ESD)市場で最大シェアを占める”
適応症に基づき、内視鏡的粘膜下層剥離術(ESD)市場は食道がん胃がん、大腸がんに区分されます。2021年の内視鏡的粘膜下層剥離術(ESD)市場で最大のシェアを占めるのは胃がんセグメントです。このセグメントの大きなシェアは、米国、中国、日本、インドにおける老人人口の増加と胃がんの罹患率の上昇に起因しています。

“予測期間中、病院セグメントが内視鏡的粘膜下層剥離術(ESD)市場を占める見込み”
エンドユーザーに基づいて、内視鏡的粘膜下層剥離術(ESD)市場は、外来手術センター、病院、専門クリニック、およびその他のエンドユーザーにセグメント化されます。予測期間中、内視鏡的粘膜下層剥離術(ESD)市場で最大のシェアを占めるのは病院セグメントで、これは一人当たり所得の増加と医療意識の高まりによるものです。

“2021年の内視鏡的粘膜下層剥離術(ESD)市場は北米が独占”
2021年に内視鏡的粘膜下層剥離術(ESD)市場を占めるのは北米です。世界市場における北米の大きなシェアは、米国における内視鏡的処置に対する有利な償還政策、癌の有病率の増加、新しい機器の購入や新しい内視鏡的処置を採用するための病院による高い投資、内視鏡技術を向上させるための研究活動への強い注力、さらにカナダの病院による新しい資金調達モデルの導入に起因しています。

この調査には、部品サプライヤーからティア1企業、OEMに至るまで、さまざまな業界専門家の洞察が含まれています。主な内訳は以下の通りです:
- 企業タイプ別 – ティア1 34%, ティア2 38% ティア3 – 28%
- 役職別 – Cレベル – 26%、マネージャーおよびその他レベル – 74%
- 地域別 – 北米 – 17%、ヨーロッパ – 39%、アジア太平洋 – 28%

内視鏡的粘膜下層剥離術(ESD)の主要企業
内視鏡的粘膜下層剥離術(ESD)市場の主要プレイヤーは、Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China)です。

調査範囲
当レポートでは、内視鏡的粘膜下層剥離術(ESD)市場を分析し、製品、適応症、エンドユーザー、地域などの様々なセグメントに基づいて、市場規模や今後の成長可能性を推計することを目的としています。また、市場で入手可能な様々な内視鏡的粘膜下層剥離術(ESD)製品の製品ポートフォリオマトリックスも掲載しています。また、同市場における主要企業の競合分析も提供しており、企業プロフィール、製品提供、主要市場戦略などを掲載しています。

レポート購入の理由
本レポートは、既存企業だけでなく、新規参入企業や小規模企業も市場の動向を把握するのに役立ちます。本レポートを購入された企業は、以下の戦略のいずれか、または任意の組み合わせを使用して、市場での地位を強化することができます。

本レポートでは、以下の点について考察しています:
- 市場参入: 内視鏡的粘膜下層剥離術(ESD)の世界市場におけるトップ企業が提供する製品ポートフォリオに関する包括的な情報。製品別、適応症別、エンドユーザー別、地域別に市場を分析しています。
- 製品の強化/革新: 世界の内視鏡的粘膜下層剥離術(ESD)市場における今後の動向や製品発売に関する詳細な洞察。
- 市場開発: 製品別、適応症別、エンドユーザー別、地域別の有利な新興市場に関する包括的情報。
- 市場の多様化: 世界の内視鏡的粘膜下層剥離術(ESD)市場における新製品や製品強化、成長地域、最近の開発、投資に関する詳細な情報。
- 競合評価: 内視鏡的粘膜下層剥離術(ESD)の世界市場における主要企業の市場シェア、成長戦略、製品提供、競合のリーダーシップマッピング、能力に関する詳細な評価。

❖ レポートの目次 ❖

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION 28
1.4 YEARS CONSIDERED 29
1.5 CURRENCY CONSIDERED 29
TABLE 1 STANDARD CURRENCY CONVERSION RATES 29
1.6 SCOPE-RELATED LIMITATIONS 30
1.7 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 31
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 33
FIGURE 3 PRIMARY SOURCES 33
2.1.2.1 Key data from primary sources 34
2.1.2.2 Key industry insights 35
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 35
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION 38
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021) 39
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 40
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
FIGURE 12 TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 13 DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ESTIMATION 43
2.5 STUDY ASSUMPTIONS 44
2.6 METHODOLOGY-RELATED LIMITATIONS 44
2.7 RISK ASSESSMENT 44
TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 44
3 EXECUTIVE SUMMARY 45
FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 45
FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION) 46
FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 46
FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 47
4 PREMIUM INSIGHTS 48
4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW 48
FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH 48
4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY 49
FIGURE 19 GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021 49
4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX 50
FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 50
4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX 51
FIGURE 21 NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD 51
4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS 51
FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Increasing use of endoscopy in detection and treatment procedures 53
5.2.1.2 Rising prevalence of cancer 53
FIGURE 24 GLOBAL CANCER INCIDENCE, 2008–2030 54
5.2.1.3 Growing geriatric population 54
FIGURE 25 SHARE OF GERIATRIC POPULATION, BY REGION (2010–2030) 55
TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65–85+), 2020 VS. 2040 55
5.2.2 RESTRAINTS 55
5.2.2.1 Dearth of skilled professionals 55
5.2.2.2 High overhead cost of ESD procedures with limited reimbursements 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Growing demand for minimally invasive procedures 56
5.2.3.2 Growing investments in research and development of endoscopy technology 56
TABLE 4 MAJOR DEVELOPMENTS 57
5.2.3.3 Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries 57
5.2.4 CHALLENGES 58
5.2.4.1 Higher rate of complications 58
5.2.4.2 Risk of post-operative infection 58
5.3 INDUSTRY TRENDS 59
5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION 59
5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION 60
5.4 REGULATORY ANALYSIS 61
5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
5.4.2 NORTH AMERICA 63
5.4.2.1 US 63
5.4.2.2 Canada 63
5.4.3 EUROPE 63
5.4.3.1 Germany 64
5.4.3.2 France 64
5.4.3.3 UK 64
5.4.3.4 Italy 65
5.5 ECOSYSTEM MARKET MAP 65
FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP 66
5.6 VALUE CHAIN ANALYSIS 66
FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS 67
5.7 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER’S FIVE FORCES ANALYSIS 67
5.7.1 THREAT OF NEW ENTRANTS 68
5.7.1.1 High capital requirement 68
5.7.1.2 High preference for products from well-established brands 68
5.7.2 THREAT OF SUBSTITUTES 68
5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection 68
5.7.3 BARGAINING POWER OF SUPPLIERS 68
5.7.3.1 Presence of several raw material suppliers 69
5.7.3.2 Supplier switching cost 69
5.7.4 BARGAINING POWER OF BUYERS 69
5.7.4.1 Limited number of companies offering premium products at global level 69
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
5.7.5.1 Increasing demand for high-quality and innovative products 69
5.7.5.2 Lucrative growth potential in emerging markets 69
5.8 INDICATIVE PRICING MODEL ANALYSIS 69
TABLE 9 AVERAGE SELLING PRICE, BY PRODUCT (USD) 70
5.9 PATENT ANALYSIS 70
5.9.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 70
FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022 71
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS 71
FIGURE 29 TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015–2022 71
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 72
FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015–2022 72
5.10 SUPPLY CHAIN ANALYSIS 72
FIGURE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN 73
5.11 KEY CONFERENCES AND EVENTS DURING 2022–2023 74
TABLE 10 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 74
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 75
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 75
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 75
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS 75
5.12.2 BUYING CRITERIA 75
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 75
TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 76
6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT 77
6.1 INTRODUCTION 78
TABLE 13 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 78
6.2 GASTROSCOPES AND COLONOSCOPES 78
6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH 78
TABLE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 KNIVES 80
6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH 80
TABLE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.4 INJECTION AGENTS 81
6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH 81
TABLE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.5 TISSUE RETRACTORS 82
6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS 82
TABLE 17 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020–2027 (USD MILLION) 82
6.6 GRASPERS/CLIPS 83
6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND 83
TABLE 18 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.7 OTHER PRODUCTS 84
TABLE 19 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 84
7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION 85
7.1 INTRODUCTION 86
TABLE 20 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 86
TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES) 86
7.2 STOMACH CANCER 87
7.2.1 STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS 87
TABLE 22 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020–2040) 87
TABLE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 24 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES) 88
7.3 COLON CANCER 89
7.3.1 COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE 89
TABLE 25 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020–2040) 89
TABLE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES) 90
7.4 ESOPHAGEAL CANCER 91
7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE 91
TABLE 28 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020–2040) 91
TABLE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES) 92
8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER 93
8.1 INTRODUCTION 94
TABLE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 94
8.2 HOSPITALS 94
8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH 94
TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 95
8.3 SPECIALTY CLINICS 95
8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH 95
TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 96
8.4 AMBULATORY SURGICAL CENTERS 97
8.4.1 GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS 97
TABLE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8.5 OTHER END USERS 98
TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 99
9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION 100
9.1 INTRODUCTION 101
FIGURE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 101
TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020–2027 (USD MILLION) 102
9.2 NORTH AMERICA 102
FIGURE 35 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT 103
TABLE 37 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 38 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104
TABLE 39 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 104
TABLE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 104
9.2.1 US 105
9.2.1.1 US is largest market for endoscopic submucosal dissection products 105
TABLE 41 US: MACROECONOMIC INDICATORS 106
TABLE 42 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 106
TABLE 43 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 106
TABLE 44 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 107
9.2.2 CANADA 107
9.2.2.1 Slower healthcare development in Canada over past decade to restrain growth 107
TABLE 45 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040 108
TABLE 46 CANADA: MACROECONOMIC INDICATORS 109
TABLE 47 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 48 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 109
TABLE 49 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 110
9.3 EUROPE 110
TABLE 50 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 51 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 52 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 111
TABLE 53 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 111
9.3.1 GERMANY 112
9.3.1.1 Germany to account for largest share of European market 112
TABLE 54 GERMANY: MACROECONOMIC INDICATORS 112
TABLE 55 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 56 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 113
TABLE 57 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 113
9.3.2 FRANCE 114
9.3.2.1 High-quality healthcare system offering coverage to all citizens to support market growth 114
TABLE 58 FRANCE: MACROECONOMIC INDICATORS 114
TABLE 59 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 60 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 115
TABLE 61 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 115
9.3.3 UK 116
9.3.3.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market 116
TABLE 62 UK: MACROECONOMIC INDICATORS 116
TABLE 63 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 117
TABLE 64 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 117
TABLE 65 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 117
9.3.4 ITALY 118
9.3.4.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth 118
TABLE 66 ITALY: MACROECONOMIC INDICATORS 118
TABLE 67 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 68 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 119
TABLE 69 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 119
9.3.5 SPAIN 120
9.3.5.1 Rising prevalence of cancer to drive market growth 120
TABLE 70 SPAIN: MACROECONOMIC INDICATORS 120
TABLE 71 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120
TABLE 72 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 121
TABLE 73 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 121
9.3.6 REST OF EUROPE 121
TABLE 74 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 75 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 122
TABLE 76 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 123
9.4 ASIA PACIFIC 123
FIGURE 36 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT 124
TABLE 77 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 78 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 79 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 125
TABLE 80 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 126
9.4.1 JAPAN 126
9.4.1.1 Supportive medical device reimbursement policies to drive market growth 126
TABLE 81 JAPAN: MACROECONOMIC INDICATORS 127
TABLE 82 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 83 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 127
TABLE 84 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 128
9.4.2 CHINA 128
9.4.2.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth 128
TABLE 85 CHINA: MACROECONOMIC INDICATORS 129
TABLE 86 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 129
TABLE 87 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 129
TABLE 88 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 130
9.4.3 INDIA 130
9.4.3.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth 130
TABLE 89 INDIA: MACROECONOMIC INDICATORS 131
TABLE 90 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 131
TABLE 91 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 131
TABLE 92 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 132
9.4.4 REST OF ASIA PACIFIC 132
TABLE 93 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 133
TABLE 94 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 133
TABLE 95 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 133
9.5 LATIN AMERICA 134
9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH 134
TABLE 96 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 135
TABLE 97 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 135
TABLE 98 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 135
9.6 MIDDLE EAST AND AFRICA 136
9.6.1 HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES 136
TABLE 99 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 136
TABLE 100 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020–2027 (USD MILLION) 137
TABLE 101 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10 COMPETITIVE LANDSCAPE 138
10.1 INTRODUCTION 138
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 138
10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS 139
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET 139
10.4 MARKET SHARE ANALYSIS 139
FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021) 140
10.5 COMPANY FOOTPRINT ANALYSIS 140
10.5.1 FOOTPRINT OF COMPANIES, BY PRODUCT 141
10.5.2 FOOTPRINT OF COMPANIES, BY END USER 142
10.5.3 FOOTPRINT OF COMPANIES, BY REGION 143
10.6 COMPANY EVALUATION MATRIX 144
10.6.1 STARS 144
10.6.2 EMERGING LEADERS 144
10.6.3 PERVASIVE PLAYERS 144
10.6.4 PARTICIPANTS 144
FIGURE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX 145
10.7 COMPETITIVE BENCHMARKING 146
TABLE 102 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES 146
10.8 COMPETITIVE SCENARIO 146
10.8.1 PRODUCT LAUNCHES 147
TABLE 103 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019–DECEMBER 2022) 147
10.8.2 DEALS 148
TABLE 104 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019–DECEMBER 2022) 148
10.8.3 OTHER DEVELOPMENTS 149
TABLE 105 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019–DECEMBER 2022) 149
11 COMPANY PROFILES 150
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 KEY PLAYERS 150
11.1.1 OLYMPUS CORPORATION 150
TABLE 106 OLYMPUS CORPORATION: BUSINESS OVERVIEW 150
FIGURE 40 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022) 151
11.1.2 FUJIFILM HOLDINGS CORPORATION 154
TABLE 107 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 154
FIGURE 41 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021) 155
11.1.3 BOSTON SCIENTIFIC CORPORATION 158
TABLE 108 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 158
FIGURE 42 COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021) 159
11.1.4 MEDTRONIC 161
TABLE 109 MEDTRONIC: BUSINESS OVERVIEW 161
FIGURE 43 COMPANY SNAPSHOT: MEDTRONIC (2022) 162
11.1.5 SUMITOMO BAKELITE CO., LTD. 164
TABLE 110 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW 164
FIGURE 44 COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021) 165
11.1.6 CREO MEDICAL GROUP PLC 167
TABLE 111 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW 167
FIGURE 45 COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021) 167
11.1.7 HOYA CORPORATION 170
TABLE 112 HOYA CORPORATION: BUSINESS OVERVIEW 170
FIGURE 46 COMPANY SNAPSHOT: HOYA CORPORATION (2022) 171
11.1.8 CONMED CORPORATION 172
TABLE 113 CONMED CORPORATION: BUSINESS OVERVIEW 172
FIGURE 47 COMPANY SNAPSHOT: CONMED CORPORATION (2021) 173
11.1.9 STERIS PLC 174
TABLE 114 STERIS PLC: BUSINESS OVERVIEW 174
FIGURE 48 COMPANY SNAPSHOT: STERIS PLC (2022) 175
11.1.10 MTW ENDOSKOPIE MANUFAKTUR 177
TABLE 115 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW 177
11.2 OTHER PLAYERS 178
11.2.1 OVESCO ENDOSCOPY AG 178
TABLE 116 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW 178
11.2.2 ZEON MEDICAL INC. 179
TABLE 117 ZEON MEDICAL INC.: BUSINESS OVERVIEW 179
11.2.3 MICRO-TECH ENDOSCOPY 180
TABLE 118 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW 180
11.2.4 KARL STORZ SE & CO. KG 182
TABLE 119 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW 182
11.2.5 COOK MEDICAL 183
TABLE 120 COOK MEDICAL: BUSINESS OVERVIEW 183
11.2.6 LEO MEDICAL CO., LTD. 185
TABLE 121 LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW 185
11.2.7 ERBE ELEKTROMEDIZIN GMBH 186
TABLE 122 ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW 186
11.2.8 TAEWOONG MEDICAL CO., LTD. 187
TABLE 123 TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW 187
11.2.9 DCC HEALTHCARE LIMITED 188
TABLE 124 DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW 188
11.2.10 KOSSEN CO., LTD. 189
TABLE 125 KOSSEN CO., LTD.: BUSINESS OVERVIEW 189
11.2.11 INNOVAMEDICA S.P.A. 190
TABLE 126 INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW 190
11.2.12 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD. 191
TABLE 127 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 191
11.2.13 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD. 192
TABLE 128 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW 192
11.2.14 BEIJING ZKSK TECHNOLOGY CO., LTD. 193
TABLE 129 BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW 193
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 194
12.1 DISCUSSION GUIDE 194
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 199
12.3 CUSTOMIZATION OPTIONS 201
12.4 RELATED REPORTS 201
12.5 AUTHOR DETAILS 202



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の内視鏡的粘膜下層剥離術(ESD)市場:製品別(把持器、クリップ、胃カメラ、大腸カメラ)、疾患別、エンドユーザー別(Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆